However, current clinical treatment using Topo II or Hsp90 inhibitors alone is not sufficiently ideal, and combined drug research shows that Topo II poisons and Hsp90 inhibitors have a synergistic effect in tumor treatment [20,21,22,23,24]. The gene discussed is HSP90AA1; the disease is neoplasm.